ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 617

$766K Total Retail Price of All Prescriptions

Rank: 15 out of 617

488 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 488 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 488 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 14,325 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
TRAMADOL HCL 606 547 1 15
WARFARIN SODIUM 568 555 2 7
LEVOTHYROXINE SODIUM 540 478 3 1
SIMVASTATIN 512 500 4 2
GABAPENTIN 483 456 5 16
FUROSEMIDE 464 447 6 4
LISINOPRIL 435 425 7 5
OMEPRAZOLE 433 404 8 3
AMLODIPINE BESYLATE 409 380 9 6
CRESTOR 376 355 10 28
DONEPEZIL HCL 290 290 11 30
METFORMIN HCL 277 262 12 9
HYDROCODONE-ACETAMINOPHEN 249 149 S3 13 8
POTASSIUM CHLORIDE 239 239 14 10
ATORVASTATIN CALCIUM 220 196 15 14
PREDNISONE 217 204 16 31
NAMENDA 198 198 17 35
CITALOPRAM HBR 195 191 18 18
TAMSULOSIN HCL 177 177 19 26
CARVEDILOL 171 165 20 19
LOSARTAN POTASSIUM 158 158 21 22
BYSTOLIC 158 156 21 64
METOPROLOL SUCCINATE 151 149 23 12
PRAVASTATIN SODIUM 148 83 24 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 122 25 29
MELOXICAM 138 136 26 24
ROPINIROLE HCL 122 106 27 66
POLYETHYLENE GLYCOL 3350 119 115 28 32
DILTIAZEM ER 118 118 29 81
FENOFIBRATE 116 105 30 58
METOPROLOL TARTRATE 109 100 31 11
RISPERIDONE 109 109 31 71
CELEBREX 108 103 33 63
DIVALPROEX SODIUM 105 64 34 111
HYDROCHLOROTHIAZIDE 105 104 34 13
ALLOPURINOL 103 92 36 27
SERTRALINE HCL 100 38 37 20
ENABLEX 99 99 38 229
AMOXICILLIN 95 79 39 135
FENTANYL 89 58 S2 40 45
RAMIPRIL 89 87 40 67
ENALAPRIL MALEATE 89 87 40 34
ATENOLOL 88 88 43 17
ESCITALOPRAM OXALATE 87 84 44 65
TRILIPIX 85 82 45 171
PANTOPRAZOLE SODIUM 85 81 45 37
TOPIRAMATE 85 14 45 149
NIASPAN 80 79 48 103
FAMOTIDINE 79 24 49 54
ADVAIR DISKUS 77 69 50 38
LOSARTAN-HYDROCHLOROTHIAZIDE 76 76 51 46
CYMBALTA 74 57 52 49
ISOSORBIDE MONONITRATE ER 72 72 53 52
TIZANIDINE HCL 72 0 53 180
NIFEDICAL XL 69 69 55 242
DOXAZOSIN MESYLATE 69 69 55 79
VESICARE 69 69 55 95
PHENYTOIN SODIUM EXTENDED 69 69 55 121
TRICOR 68 68 59 83
CEFDINIR 68 62 59 169
DIOVAN HCT 66 65 61 97
PAROXETINE HCL 65 65 62 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 62 62 91
BACLOFEN 65 0 62 146
MIRTAZAPINE 63 63 65 50
CEPHALEXIN 62 55 66 68
FLUOXETINE HCL 62 58 66 73
TERAZOSIN HCL 60 0 68 96
PREMARIN 59 53 R 69 108
CLONIDINE HCL 57 57 70 55
CIPROFLOXACIN HCL 56 55 71 60
OLANZAPINE 56 56 71 139
SPIRIVA 54 31 73 61
DIGOXIN 54 54 73 48
DICYCLOMINE HCL 53 53 75 226
CLOPIDOGREL 52 46 76 53
ACTOS 51 47 77 85
FLUTICASONE PROPIONATE 51 51 77 36
AVODART 51 51 77 144
ZOLPIDEM TARTRATE 50 34 80 23
MECLIZINE HCL 50 50 80 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.